Atea Pharmaceuticals, Inc. - common stock (AVIR) analyst actions
Rating and price-target actions on AVIR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AVIR overview →
1 measured AVIR analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus | Press release | -1.90% | -1.05% |
Keep exploring
More AVIR: earnings → · SEC filings → · AVIR overview →